HCPCS Code Q0239

Injection, bamlanivimab-xxxx, 700 mg
Code effective Apr 17, 2021

HCPCS Section
Miscellaneous Services (Temporary Codes)

Q0239 is a valid 2026 HCPCS code meaning Injection, bamlanivimab-xxxx, 700 mg or (Bamlanivimab-xxxx) for short. HCPCS Q0239 has been effective since 04/17/2021 and applies to Pneumococcal/flu vaccine.

HCPCS Code Details - Q0239

HCPCS Level II Code
Section Q - Miscellaneous Services (Temporary Codes)
HCPCS Code Q0239
Description

Long description:
Injection, bamlanivimab-xxxx, 700 mg

Short description:
Bamlanivimab-xxxx

HCPCS Pricing indicator 54 - Vaccinations
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1G - Immunizations/Vaccinations
HCPCS Action code N - No maintenance for this code
Type of service V - Pneumococcal/flu vaccine
Effective date Effective Apr 17, 2021
Date added Added Nov 09, 2020
Termination date Apr 16, 2021

See also

  • HCPCS Q0238 · Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

  • HCPCS Q0240 · Injection, casirivimab and imdevimab, 600 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.